ArticleJournal of clinical medicine2021

AIM2 Inflammasome in Tumor Cells as a Biomarker for Predicting the Treatment Response to Antiangiogenic Therapy in Epithelial Ovarian Cancer Patients.

Po-Chao Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.